Prevalence of genetic variants in SERPINB2 and PKNOX1 genes in erythema nodosum leprosum patients from southern Brazil
The Journal of Infection in Developing Countries · 2025
DOI: 10.3855/jidc.20688 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2025. Verfasst von Simone Perazzoli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre/UFCSPA, Porto Alegre, RS, Brazil. Hauptthemen laut MEDLINE: Erythema Nodosum, Genetic Predisposition to Disease, Leprosy, Lepromatous. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Erythema nodosum leprosum (ENL) is a humoral immune response to Mycobacterium leprae that is characterized by erythematous nodules, and may or may not be associated with systemic symptoms. Thalidomide is the primary treatment for ENL in Brazil, but peripheral neuropathy (PN) is a significant adverse effect. Genetic variants in SERPINB2 and PKNOX1 genes have been implicated in the predisposition to develop thalidomide-induced peripheral neuropathy (TiPN) in patients with multiple myeloma. This study evaluated the prevalence of the polymorphisms in SERPINB2 and PKNOX1 in ENL patients. Methodology: A cross-sectional study was conducted in a sample of ENL patients from southern Brazil to assess the presence of genetic variants of SERPINB2 and PKNOX1.
Results
Forty-seven patients with ENL were included. The prevalence of SERPINB2 (rs6103) was 66% for the C allele and 34% for the G allele, and the prevalence of PKNOX1 (rs2839629) was 75% for the A allele and 25% for the G allele. There was significantly relevant presence of the PKNOX1 (rs2839629) A allele in patients with ENL (p < 0.001). In the case of patients with PN, the presence of the C genotype for rs6103 (SERPINB2) was 85% in homozygosity and 77.3% in heterozygosity; and the presence of the A genotype for rs2839629 (PKNOX1) was 84% in homozygosity and 80% in heterozygosity.
Conclusions
Polymorphisms in SERPINB2 and PKNOX1 were identified in patients with ENL, with emphasis on PKNOX1. If confirmed by more robust future studies, these findings may guide clinical decisions and treatment guidelines for ENL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Graduate Program in Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre/UFCSPA, Porto Alegre, RS, Brazil.
- Graduate Program in Genetics and Molecular Biology, Universidade Federal do Rio Grande do Sul/UFRGS, Porto Alegre, RS, Brazil.
- Graduate Program in Medical Sciences, Medical School, Universidade Federal do Rio Grande do Sul/UFRGS, Porto Alegre, RS, Brazil.
- Service of Dermatology, Hospital de Clínicas de Porto Alegre/HCPA, Porto Alegre, RS, Brazil.
Zitieren
APA
Perazzoli, S., Fiuza, M. F., De Moraes, P. C., Heck, R., Vianna, F. S., & Bonamigo, R. R. (2025). Prevalence of genetic variants in SERPINB2 and PKNOX1 genes in erythema nodosum leprosum patients from southern Brazil. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.20688
Vancouver
Perazzoli S, Fiuza MF, De Moraes PC, Heck R, Vianna FS, Bonamigo RR. Prevalence of genetic variants in SERPINB2 and PKNOX1 genes in erythema nodosum leprosum patients from southern Brazil. The Journal of Infection in Developing Countries. 2025. doi:10.3855/jidc.20688
BibTeX
@article{Perazzoli2025,
author = {Perazzoli, Simone and Fiuza, Miriãn Fm and De Moraes, Paulo Cezar and Heck, Renata and Vianna, Fernanda Sl and Bonamigo, Renan R},
title = {Prevalence of genetic variants in SERPINB2 and PKNOX1 genes in erythema nodosum leprosum patients from southern Brazil},
journal = {The Journal of Infection in Developing Countries},
year = {2025},
doi = {10.3855/jidc.20688}
}
EUVIMED